Early Adopter ProgramReplicel's Tweet March 18th regarding the Early Adopter Program for the Dermal injector:
"We are nearly finished preparations on an Early Adopter Program for Key Opinion Leaders in three continents for pre-clinical and clinical evaluations in different applications."
I didn't read this very carefully when it was first tweeted but on further examination it looks like we are a long way from applying for FDA Approval. It looks like the device will be sent out to selected "key opinion leaders" for further "pre-clinical and clinical evaluations" (testing). It is anyones guess as to how long this round of testing will take.
Why can't they just give the shareholders a timeline.